These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22733815)

  • 1. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.
    Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M
    J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural biology of the FGF19 subfamily.
    Beenken A; Mohammadi M
    Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FGF metabolic axis.
    Li X
    Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
    Goetz R; Beenken A; Ibrahimi OA; Kalinina J; Olsen SK; Eliseenkova AV; Xu C; Neubert TA; Zhang F; Linhardt RJ; Yu X; White KE; Inagaki T; Kliewer SA; Yamamoto M; Kurosu H; Ogawa Y; Kuro-o M; Lanske B; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2007 May; 27(9):3417-28. PubMed ID: 17339340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.
    Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M
    Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects.
    Ying L; Wang L; Guo K; Hou Y; Li N; Wang S; Liu X; Zhao Q; Zhou J; Zhao L; Niu J; Chen C; Song L; Hou S; Kong L; Li X; Ren J; Li P; Mohammadi M; Huang Z
    Nat Commun; 2021 Dec; 12(1):7256. PubMed ID: 34907199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Saga of Endocrine FGFs.
    Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-receptor requirements for fibroblast growth factor-19 signaling.
    Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
    Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
    Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
    Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.
    Itoh N
    Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy.
    Itoh N; Ohta H; Konishi M
    Front Endocrinol (Lausanne); 2015; 6():154. PubMed ID: 26483756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine Fibroblast Growth Factors in Relation to Stress Signaling.
    Shimizu M; Sato R
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
    Ghanem M; Archer G; Crestani B; Mailleux AA
    Pharmacol Ther; 2024 Jul; 259():108669. PubMed ID: 38795981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine fibroblast growth factors as regulators of metabolic homeostasis.
    Kurosu H; Kuro-O M
    Biofactors; 2009; 35(1):52-60. PubMed ID: 19319846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine fibroblast growth factors in domestic animals.
    Brinker EJ; Hardcastle MR; Dittmer KE; Graff EC
    Domest Anim Endocrinol; 2024 Oct; 89():106872. PubMed ID: 39059301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
    Zhao L; Niu J; Lin H; Zhao J; Liu Y; Song Z; Xiang C; Wang X; Yang Y; Li X; Mohammadi M; Huang Z
    EBioMedicine; 2019 Oct; 48():462-477. PubMed ID: 31631034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.
    Itoh N; Ornitz DM
    J Biochem; 2011 Feb; 149(2):121-30. PubMed ID: 20940169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring mechanisms of FGF signalling through the lens of structural biology.
    Goetz R; Mohammadi M
    Nat Rev Mol Cell Biol; 2013 Mar; 14(3):166-80. PubMed ID: 23403721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factors: new insights, new targets in the management of diabetes.
    Kyrou I; Weickert MO; Gharanei S; Randeva HS; Tan BK
    Minerva Endocrinol; 2017 Sep; 42(3):248-270. PubMed ID: 27412358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.